Trial Information

Summary: PET mapping of the serotonin receptor differences in unipolar major depression and suicidal behavior

This study uses brain-imaging technology (PET scans) to visualize and research changes in brain chemistry that may cause an episode of depression and/or be associated with suicidal behavior. In exchange for study participation, patients receive no-cost outpatient treatment for six months, or inpatient treatment, depending on their clinical needs.

Patient Inclusion Criteria

  • Ages 18 to 65
  • Meets criteria for Major Depressive Disorder
  • Currently depressed

Patient Exclusion Criteria

  • Unstable medical condition
  • Pregnancy
  • Current alcohol or substance abuse

For more information,

Contact:

Anna Sapozhnikova, Research Coordinator
New York State Psychiatric Institute
1051 Riverside Dr.
New York, NY 10032
Telephone: 212-543-5834
Email:

Profile Page: New York State Psychiatric Institute, New York, NY

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:30:12 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA